InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: massulo52 post# 328525

Sunday, 03/07/2021 4:57:21 PM

Sunday, March 07, 2021 4:57:21 PM

Post# of 425795
m-

united healthcare will no longer be covering Vascepa or generic Icosapent Ethyl for severe hypertriglyceridemia (Triglycerides >500). Instead they will cover generic Lovaza and/or Fibrates

To cancel the VHTG indication from the label is futile, the indication will exist independently from Vascepa ('s label) ... however modify the coverage agreements - terminate the VHTG part - is a brilliant step. Let's hope all HCP will do the same. (Assumping it is Amarin's action, plan going forward ... let the 10% of the market for the gV WITHOUT coverage.)

Best,
G

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News